ABBOTT LABORATORIES — Director's Dealing 2015

Mar 10, 2015

SEC FORM 3 Page 1 of 2

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person* BIRD ROGER (Last) (First) (Middle) 100 ABBOTT PARK ROAD (Street) ABBOTT PARK IL 60064 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 03/01/2015	3. Issuer Name and Ticker or Trading Symbol ABBOTT LABORATORIES [ ABT ]
			4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Senior Vice President		5. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)			2. Amount of Securities Beneficially Owned (Instr. 4)		3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common shares without par value			42,010		D
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)(1)	02/17/2007	02/16/2016	Common shares	4,509	21.2194	D
Option (right to buy)(1)	02/17/2008	02/16/2016	Common shares	4,509	21.2194	D
Option (right to buy)(1)	02/17/2009	02/16/2016	Common shares	4,509	21.2194	D
Option (right to buy)(1)	02/16/2008	02/15/2017	Common shares	3,607	25.2461	D
Option (right to buy)(1)	02/16/2009	02/15/2017	Common shares	3,607	25.2461	D
Option (right to buy)(1)	02/15/2010	02/14/2018	Common shares	3,677	26.6973	D
Option (right to buy)(1)	02/15/2010	02/14/2018	Common shares	3,677	26.6973	D
Option (right to buy)(1)	02/15/2011	02/14/2018	Common shares	3,676	26.6973	D

http://www.sec.gov/Archives/edgar/data/1800/000117911015004683/xslF345X02/edgar.xml

---

SEC FORM 3 Page 2 of 2

| Table II - Derivative Securities Beneficially Owned

(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date
(Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy) (1)	03/31/2009	03/30/2018	Common shares	625	26.1976	D
Option (right to buy) (1)	03/31/2010	03/30/2018	Common shares	624	26.1976	D
Option (right to buy) (1)	03/31/2011	03/30/2018	Common shares	624	26.1976	D
Option (right to buy) (2)	02/20/2016	02/19/2025	Common shares	38,231	47	D
Option (right to buy) (2)	02/20/2017	02/19/2025	Common shares	38,230	47	D
Option (right to buy) (2)	02/20/2018	02/19/2025	Common shares	38,231	47	D

Explanation of Responses:

1. Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
2. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

John A. Berry, by power of attorney for Roger Bird 03/10/2015

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 5 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

http://www.sec.gov/Archives/edgar/data/1800/000117911015004683/xslF345X02/edgar.xml 3/11/2015